ALBLFALBERT LABS INTL CORP.

About ALBERT LABS INTL CORP. (ALBLF)

ALBERT LABS INTL CORP. (ALBLF) is a N/A company headquartered in Burnaby, BC, Canada whose shares trade over-the-counter on the Expert Market tier.

Albert Labs International Corp. is a research and drug development company addressing mental health care needs. Through a succinct clinical pathway, focusing on Real World Evidence (RWE) Albert Labs look to commercialize its psychedelic-based treatments, and in doing so deliver psychedelic-assisted psychotherapy to patients sooner. Focused on accelerating access and faster approvals, Albert Labs put patients with urgent and unmet needs first as it develops licensed medicines to treat a variety of mental health conditions. Cancer-related distress, an initial focus of Albert Labs development program is thought to affect over 16 million patients worldwide.

ALBLF key facts

Ticker symbol

ALBLF

Market tier

Expert Market

Headquarters

Burnaby, BC, Canada

Shares outstanding

74,413,267

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

12/31

Explore more: Expert Market stocks · OTC stocks starting with A